28 results on '"Mognetti, Thomas"'
Search Results
2. Colorectal Adenocarcinoma Mimicking Neuroendocrine Neoplasia on 18F-FDOPA PET/CT
3. Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment
4. Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment
5. Unintentional Intra-arterial Injection of 177Lu-PSMA-1 in a Patient With a Peritoneal Carcinosis Secondary to a Metastatic Prostate Cancer
6. PET metabolic tumor volume as a new prognostic factor in childhood rhabdomyosarcoma
7. Yttrium-90 quantitative phantom study using digital photon counting PET
8. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center
9. Cholesterol Granuloma
10. TEP-FDG et cancer du sein
11. Yttrium-90 Quantitative Phantom Study Using Digital Photon Counting PET
12. Discordant results in 18F-FDG PET/CT and ultrasound-based assessment for axillary lymph node metastasis detection: A large retrospective analysis in 560 patients with breast cancer
13. Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
14. Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT
15. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT
16. FDOPA Patterns in Adrenal Glands
17. Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
18. Impact of 18 f-Fluoro-Deoxyglucose Positron Emission Tomography Imaging in the Management of Mantle Cell Lymphoma
19. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients
20. PET/CT-guided percutaneous biopsy for diagnosis of MPNST in Neufibromatosis Type 1 (NF1).
21. Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
22. An open-label randomized, multicenter, phase II study on neoadjuvant treatment with trastuzumab plus docetaxel versus trastuzumab plus docetaxel plus bevacizumab according to positron emission tomography (PET) value modification in patients with early stage HER2-positive breast cancer (AVATAXHER): Design description.
23. Prognostic Value of 18F-FDG Positron Emission Tomography Used for Assessment of the First Line Therapy in 410 Diffuse Large B-Cell Lymphoma Patients: A Daily Practice Evaluation Before and After the Prescription of This Metabolic Imaging Technique,
24. Additional Benefit of F-18 FDG PET/CT in the Staging and Follow-up of Pediatric Rhabdomyosarcoma
25. Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors
26. F-18 FDG PET/CT Imaging in a Case of Primary Choriocarcinoma in the Retroperitoneum
27. Development of a database of realistic simulated whole body [18F]FDG PET images for lymphoma
28. Is non-attenuation-corrected PET inferior to body attenuation-corrected PET or PET/CT in lung cancer?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.